Literature DB >> 27208514

Is plasma GABA level a biomarker of Post-Traumatic Stress Disorder (PTSD) severity? A preliminary study.

Marion Trousselard1, Bertrand Lefebvre2, Lionel Caillet3, Yann Andruetan4, Franck de Montleau5, Josiane Denis2, Frédéric Canini6.   

Abstract

OBJECTIVES: An increased reactivity to the environment is observed in Post-Traumatic Stress Disorder (PTSD). It would be related to impairment of the Gamma Amino Butyric Acid (GABA) neurotransmission. The study aimed to evaluate plasma GABA concentration as a candidate for PTSD severity biomarker.
METHODS: This hypothesis was studied in 17 PTSD patients and 17 healthy Controls using classic and emotional Stroop paradigms. Plasma GABA concentrations were assessed before and after both Stroop tests to evaluate GABA basal tone and GABA reactivity (change in GABAp), respectively.
RESULTS: During baseline, PTSD had lower plasma GABA concentrations than the Controls. After the Stroop conflicts GABA reactivity was also lower in PTSD than in the Controls. The GABA baseline tone was negatively correlated with the severity of the PTSD symptoms. This relation was only marginally observed for GABA reactivity. The results produced a trend due to the small size of the sample compared to the number of statistical results given.
CONCLUSION: Altogether, the reduced GABA concentration observed in PTSD could be considered as a possible biomarker for PTSD severity.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; PTSD; Plasma GABA; Stroop test; Trauma

Mesh:

Substances:

Year:  2016        PMID: 27208514     DOI: 10.1016/j.psychres.2016.05.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Plasma gamma-aminobutyric acid (GABA) levels and posttraumatic stress disorder symptoms in trauma-exposed women: a preliminary report.

Authors:  Kimberly A Arditte Hall; Sumaiya E DeLane; George M Anderson; Tiffany R Lago; Rachel Shor; Weiwei Wang; Ann M Rasmusson; Suzanne L Pineles
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

Review 2.  Neurotransmitter, Peptide, and Steroid Hormone Abnormalities in PTSD: Biological Endophenotypes Relevant to Treatment.

Authors:  Ann M Rasmusson; Suzanne L Pineles
Journal:  Curr Psychiatry Rep       Date:  2018-07-17       Impact factor: 5.285

Review 3.  Altered GABAergic Signaling in Brain Disease at Various Stages of Life.

Authors:  Yoo Sung Kim; Bo-Eun Yoon
Journal:  Exp Neurobiol       Date:  2017-05-19       Impact factor: 3.261

Review 4.  Proton Magnetic Resonance Spectroscopy in Post-Traumatic Stress Disorder-Updated Systematic Review and Meta-Analysis.

Authors:  Kelley M Swanberg; Leonardo Campos; Chadi G Abdallah; Christoph Juchem
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-10-09

5.  Sex, Pramipexole and Tiagabine Affect Behavioral and Hormonal Response to Traumatic Stress in a Mouse Model of PTSD.

Authors:  Natalia Malikowska-Racia; Kinga Salat; Joanna Gdula-Argasinska; Piotr Popik
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

6.  Genetic deletion of the 67-kDa isoform of glutamate decarboxylase alters conditioned fear behavior in rats.

Authors:  Kazuyuki Fujihara; Takumi Sato; Yoshiki Miyasaka; Tomoji Mashimo; Yuchio Yanagawa
Journal:  FEBS Open Bio       Date:  2020-12-30       Impact factor: 2.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.